glp-1 prescriptions growth slowdown 2024 increase by 364% whilst BMS declines by 42% Contributor: Yearly Trends in Coverage

Common brand names for GLP-1 drugs include Wegovy, Ozempic, Mounjaro and Saxenda

These peptides are not FDA-approved for disease treatment and are intended for research and educational purposes

Their core mechanism of action is to inhibit glucagon secretion and regulate body weight

Wegovy and phentermine should be avoided in women who are pregnant due to the risk of harm to an unborn baby

Human research has found that MK-677 can enhance pulsatile GH secretion and increase fat-free mass over 12 months in older adults. MK-677 is relevant for topical completeness, but it is a different category from CJC-1295, Sermorelin, Tesamorelin, and Ipamorelin because it is not a peptide

In addition, MIC B12 injections may also be helpful for those with certain medical conditions, such as pernicious anemia and certain neurological disorders